A Phase II Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Biliary Tract Cancers
Clinical Colorectal Cancer - United States
doi 10.1016/j.clcc.2013.12.005
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2014
Authors
Publisher
Elsevier BV